1. BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design;Babu;J. Med. Chem.,2000
2. Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir;Bantia;Antimicrob. Agents Chemother.,2001
3. Biochemical methods for the characterization of influenza viruses with reduced sensitivity to 4-guanidino-Neu5Ac2en;Bethell,2000
4. Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en;Blick;Virology,1995
5. Covington, E., Mendel, D.B., Escarpe, P, Tai, C.Y., Soderbarg, K., Roberts, N.A., 1999. Phenotypic and genotypic assay of influenza neuraminidase indicates a low incidence of viral drug resistance during treatment with oseltamivir. Second International Symposium on Influenza and Other Respiratory Viruses, Grand Cayman, Cayman Islands, December 10–12.